Log in

NASDAQ:BSGMBioSig Technologies Stock Price, Forecast & News

-0.88 (-9.67 %)
(As of 08/4/2020 04:00 PM ET)
Today's Range
Now: $8.22
50-Day Range
MA: $8.26
52-Week Range
Now: $8.22
Volume1.64 million shs
Average Volume697,408 shs
Market Capitalization$214.62 million
P/E RatioN/A
Dividend YieldN/A
BioSig Technologies, Inc., a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures. It is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settings and for arrhythmia treatments. The company was founded in 2009 and is headquartered in Los Angeles, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.44 out of 5 stars

Industry, Sector and Symbol

Industry Electromedical equipment
Current SymbolNASDAQ:BSGM



Sales & Book Value

Annual SalesN/A
Book Value$0.53 per share


Net Income$-34,060,000.00


Market Cap$214.62 million
Next Earnings Date8/5/2020 (Estimated)
OptionableNot Optionable
-0.88 (-9.67 %)
(As of 08/4/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BSGM News and Ratings via Email

Sign-up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

BioSig Technologies (NASDAQ:BSGM) Frequently Asked Questions

How has BioSig Technologies' stock been impacted by COVID-19 (Coronavirus)?

BioSig Technologies' stock was trading at $3.14 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BSGM stock has increased by 161.8% and is now trading at $8.22.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of BioSig Technologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for BioSig Technologies

When is BioSig Technologies' next earnings date?

BioSig Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020.
View our earnings forecast for BioSig Technologies

How were BioSig Technologies' earnings last quarter?

BioSig Technologies Inc (NASDAQ:BSGM) released its earnings results on Monday, May, 11th. The company reported ($0.46) EPS for the quarter, missing the Zacks' consensus estimate of ($0.24) by $0.22.
View BioSig Technologies' earnings history

What price target have analysts set for BSGM?

1 analysts have issued 12-month price objectives for BioSig Technologies' stock. Their forecasts range from $9.00 to $9.00. On average, they anticipate BioSig Technologies' share price to reach $9.00 in the next twelve months. This suggests a possible upside of 9.5% from the stock's current price.
View analysts' price targets for BioSig Technologies

Has BioSig Technologies been receiving favorable news coverage?

News headlines about BSGM stock have been trending neutral recently, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BioSig Technologies earned a daily sentiment score of 0.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days.
View the latest news about BioSig Technologies

Who are some of BioSig Technologies' key competitors?

What other stocks do shareholders of BioSig Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Roku (ROKU), Amarin (AMRN), Novavax (NVAX), Pfizer (PFE), Intel (INTC), Micron Technology (MU), Advanced Micro Devices (AMD) and NVIDIA (NVDA).

Who are BioSig Technologies' key executives?

BioSig Technologies' management team includes the following people:
  • Mr. Kenneth L. Londoner M.B.A., MBA, Founder, CEO & Exec. Chairman (Age 51)
  • Mr. Steven Chaussy, Chief Financial Officer (Age 65)
  • Ms. Lora Mikolaitis, VP of Admin. (Age 46)
  • Mrs. Tiffini Wittwer, Chief Regulatory & Compliance Officer
  • Mr. John Kowalski, VP of Sales

What is BioSig Technologies' stock symbol?

BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM."

Who are BioSig Technologies' major shareholders?

BioSig Technologies' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Zeke Capital Advisors LLC (0.83%), Cambridge Investment Research Advisors Inc. (0.44%), American Financial Advisors LLC (0.09%), Valmark Advisers Inc. (0.08%), FNY Investment Advisers LLC (0.07%) and UBS Group AG (0.03%). Company insiders that own BioSig Technologies stock include Jerome B Zeldis, Kenneth L Londoner, Martha Pease, Samuel E Navarro and Steve Chaussy.
View institutional ownership trends for BioSig Technologies

Which institutional investors are selling BioSig Technologies stock?

BSGM stock was sold by a variety of institutional investors in the last quarter, including Zeke Capital Advisors LLC, and UBS Group AG.
View insider buying and selling activity for BioSig Technologies

Which institutional investors are buying BioSig Technologies stock?

BSGM stock was acquired by a variety of institutional investors in the last quarter, including American Financial Advisors LLC, Valmark Advisers Inc., FNY Investment Advisers LLC, and Cambridge Investment Research Advisors Inc.. Company insiders that have bought BioSig Technologies stock in the last two years include Jerome B Zeldis, Kenneth L Londoner, Martha Pease, Samuel E Navarro, and Steve Chaussy.
View insider buying and selling activity for BioSig Technologies

How do I buy shares of BioSig Technologies?

Shares of BSGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BioSig Technologies' stock price today?

One share of BSGM stock can currently be purchased for approximately $8.22.

How big of a company is BioSig Technologies?

BioSig Technologies has a market capitalization of $214.62 million. BioSig Technologies employs 20 workers across the globe.

What is BioSig Technologies' official website?

The official website for BioSig Technologies is www.biosig.com.

How can I contact BioSig Technologies?

BioSig Technologies' mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The company can be reached via phone at 203-409-5444 or via email at [email protected]

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.